Kerin MJ - Search Results

1

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.

Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ. Lowery AJ, et al. Among authors: kerin mj. Breast Cancer Res. 2009;11(3):R27. doi: 10.1186/bcr2257. Epub 2009 May 11. Breast Cancer Res. 2009. PMID: 19432961 Free PMC article.

2

Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.

Mc Cormack O, Chung WY, Fitzpatrick P, Cooke F, Flynn B, Harrison M, Fox E, Gallagher E, McGoldrick A, Dervan PA, McCann A, Kerin MJ. Mc Cormack O, et al. Among authors: kerin mj. Breast Cancer Res Treat. 2008 Sep;111(1):45-53. doi: 10.1007/s10549-007-9757-7. Epub 2007 Sep 26. Breast Cancer Res Treat. 2008. PMID: 17896177

3

Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones.

Potter SM, Dwyer RM, Curran CE, Hennessy E, Harrington KA, Griffin DG, Kerin MJ. Potter SM, et al. Among authors: kerin mj. Breast Cancer Res Treat. 2009 May;115(2):279-87. doi: 10.1007/s10549-008-0078-2. Epub 2008 Jun 4. Breast Cancer Res Treat. 2009. PMID: 18521742

4

The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.

Lowery AJ, Sweeney KJ, Molloy AP, Hennessy E, Curran C, Kerin MJ. Lowery AJ, et al. Among authors: kerin mj. BMC Cancer. 2008 Sep 30;8:279. doi: 10.1186/1471-2407-8-279. BMC Cancer. 2008. PMID: 18826631 Free PMC article. Clinical Trial.

5

Low penetrance breast cancer predisposition SNPs are site specific.

Mcinerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S, Jones AM, Tuohy S, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. Mcinerney N, et al. Breast Cancer Res Treat. 2009 Sep;117(1):151-9. doi: 10.1007/s10549-008-0235-7. Epub 2008 Nov 13. Breast Cancer Res Treat. 2009. PMID: 19005751

6

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.

Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. Colleran G, et al. Breast Cancer Res Treat. 2010 Jan;119(2):437-42. doi: 10.1007/s10549-009-0395-0. Epub 2009 Apr 24. Breast Cancer Res Treat. 2010. PMID: 19390964

7

Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.

McCafferty MP, McNeill RE, Miller N, Kerin MJ. McCafferty MP, et al. Among authors: kerin mj. Breast Cancer Res Treat. 2009 Aug;116(3):425-32. doi: 10.1007/s10549-009-0429-7. Epub 2009 Jun 9. Breast Cancer Res Treat. 2009. PMID: 19507020 Free article. Review.

8

Evolution of breast cancer management in Ireland: a decade of change.

Heneghan HM, Prichard RS, Devaney A, Sweeney KJ, Malone C, McLaughlin R, Kerin MJ. Heneghan HM, et al. Among authors: kerin mj. BMC Surg. 2009 Sep 18;9:15. doi: 10.1186/1471-2482-9-15. BMC Surg. 2009. PMID: 19765289 Free PMC article.

9

Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer.

Kheirelseid EA, Chang KH, Newell J, Kerin MJ, Miller N. Kheirelseid EA, et al. Among authors: kerin mj. BMC Mol Biol. 2010 Feb 1;11:12. doi: 10.1186/1471-2199-11-12. BMC Mol Biol. 2010. PMID: 20122155 Free PMC article.

10

Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.

Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Heneghan HM, et al. Among authors: kerin mj. Ann Surg. 2010 Mar;251(3):499-505. doi: 10.1097/SLA.0b013e3181cc939f. Ann Surg. 2010. PMID: 20134314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters